West Cobb, GA The Village at Old Trace 3405 Dallas Highway Suite 200 Marietta, GA 30064 East Cobb, GA Woodlawn Commons Medical Center 1121 Johnson Ferry Rd Suite 340 Marietta, GA 30068 Roswell, GA Northmeadow Medical Center 1357 Hembree Rd Suite 235 Roswell, GA 30076 Cumming, GA Cumming Town Center 2021 Market Place Blvd Cumming, GA 30041 Dunwoody, GA Dunwoody Village Shopping Center 5471 Chamblee Dunwoody Rd Dunwoody, GA 30338 Opening Fall 2026
Selective GH Release Ipamorelin Ipamorelin produces GH release without significant cortisol, prolactin, or ACTH elevation, making it the cleanest GHS-R1a agonist for isolated GH stimulation research Combined GHRH/GHRP Protocols Ipamorelin Ipamorelin's selectivity makes it the preferred GHRP partner for combination with GHRH analogs like CJC-1295 (No DAC) or sermorelin, capturing synergistic GH release without adding hormonal side effects Appetite Stimulation and Cachexia Research GHRP-6 GHRP-6 produces significant appetite stimulation through hypothalamic ghrelin signaling, making it valuable in research on wasting, cachexia, and conditions requiring increased caloric intake Long-Term GH Optimization Ipamorelin The absence of cortisol elevation and appetite disruption makes ipamorelin better suited for sustained protocols where repeated dosing over weeks or months is expected Maximum Acute GH Release GHRP-6 GHRP-6 produces higher peak GH levels than ipamorelin at comparable doses, making it preferred when the largest possible acute GH pulse is the primary research endpoint Evening or Bedtime Dosing Ipamorelin Ipamorelin does not stimulate appetite or elevate cortisol, avoiding sleep disruption from hunger and the cortisol spike that could interfere with natural nighttime GH release patterns Continue Your Research Get comparison updates We publish new head-to-head comparisons regularly
Activation of AP-1 by mutant SOD1 in NSC-34 cells mediates upregulation of Bcl2-A1, which regulates apoptosis (Kale et al., 2018)
Luger, K., Mader, A
"Ecstasy-type substances Retail and wholesale prices* and purity levels, by drug, region and country or territory"
